DNLI logo

Denali Therapeutics (DNLI) Free cash flow

annual FCF:

-$363.61M+$7.32M(+1.97%)
December 31, 2024

Summary

  • As of today (June 17, 2025), DNLI annual free cash flow is -$363.61 million, with the most recent change of +$7.32 million (+1.97%) on December 31, 2024.
  • During the last 3 years, DNLI annual FCF has fallen by -$143.72 million (-65.36%).
  • DNLI annual FCF is now -188.03% below its all-time high of $413.06 million, reached on December 31, 2020.

Performance

DNLI Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

quarterly FCF:

-$136.55M-$47.74M(-53.76%)
March 31, 2025

Summary

  • As of today (June 17, 2025), DNLI quarterly free cash flow is -$136.55 million, with the most recent change of -$47.74 million (-53.76%) on March 31, 2025.
  • Over the past year, DNLI quarterly FCF has dropped by -$20.78 million (-17.95%).
  • DNLI quarterly FCF is now -126.63% below its all-time high of $512.72 million, reached on December 31, 2020.

Performance

DNLI quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

TTM FCF:

-$384.38M-$20.78M(-5.71%)
March 31, 2025

Summary

  • As of today (June 17, 2025), DNLI TTM free cash flow is -$384.38 million, with the most recent change of -$20.78 million (-5.71%) on March 31, 2025.
  • Over the past year, DNLI TTM FCF has increased by +$40.73 million (+9.58%).
  • DNLI TTM FCF is now -192.54% below its all-time high of $415.39 million, reached on March 31, 2021.

Performance

DNLI TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

DNLI Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.0%-17.9%+9.6%
3 y3 years-65.4%-79.3%-58.2%
5 y5 years-114.5%-146.6%-99.7%

DNLI Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-65.4%+2.0%-198.2%at low-64.4%+9.6%
5 y5-year-188.0%+2.0%-126.6%at low-192.5%+9.6%
alltimeall time-188.0%+2.0%-126.6%at low-192.5%+9.6%

DNLI Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
-$136.55M(+53.8%)
-$384.38M(+5.7%)
Dec 2024
-$363.61M(-2.0%)
-$88.81M(+40.9%)
-$363.61M(-3.2%)
Sep 2024
-
-$63.02M(-34.4%)
-$375.69M(-6.6%)
Jun 2024
-
-$96.01M(-17.1%)
-$402.10M(-5.4%)
Mar 2024
-
-$115.77M(+14.7%)
-$425.11M(+14.6%)
Dec 2023
-$370.93M(+41.3%)
-$100.89M(+12.8%)
-$370.93M(+6.7%)
Sep 2023
-
-$89.43M(-24.9%)
-$347.55M(+8.2%)
Jun 2023
-
-$119.02M(+93.3%)
-$321.21M(+29.5%)
Mar 2023
-
-$61.59M(-20.5%)
-$247.99M(-5.5%)
Dec 2022
-$262.55M(+19.4%)
-$77.51M(+22.8%)
-$262.55M(+3.5%)
Sep 2022
-
-$63.10M(+37.8%)
-$253.58M(+8.5%)
Jun 2022
-
-$45.79M(-39.9%)
-$233.80M(-3.8%)
Mar 2022
-
-$76.15M(+11.1%)
-$243.00M(+10.5%)
Dec 2021
-$219.89M(-153.2%)
-$68.55M(+58.3%)
-$219.89M(-160.8%)
Sep 2021
-
-$43.31M(-21.2%)
$361.38M(-10.6%)
Jun 2021
-
-$54.99M(+3.7%)
$404.07M(-2.7%)
Mar 2021
-
-$53.04M(-110.3%)
$415.39M(+0.6%)
DateAnnualQuarterlyTTM
Dec 2020
$413.06M(-343.7%)
$512.72M(<-9900.0%)
$413.06M(-375.2%)
Sep 2020
-
-$620.00K(-98.6%)
-$150.08M(-17.9%)
Jun 2020
-
-$43.67M(-21.1%)
-$182.74M(-5.1%)
Mar 2020
-
-$55.37M(+9.8%)
-$192.51M(+13.6%)
Dec 2019
-$169.50M(-462.8%)
-$50.42M(+51.5%)
-$169.50M(+520.2%)
Sep 2019
-
-$33.28M(-37.7%)
-$27.33M(-8.0%)
Jun 2019
-
-$53.45M(+65.2%)
-$29.72M(+59.2%)
Mar 2019
-
-$32.35M(-135.3%)
-$18.67M(-140.0%)
Dec 2018
$46.72M(-158.8%)
$91.75M(-357.2%)
$46.72M(-172.5%)
Sep 2018
-
-$35.67M(-15.9%)
-$64.43M(+26.2%)
Jun 2018
-
-$42.40M(-228.3%)
-$51.05M(+90.5%)
Mar 2018
-
$33.04M(-270.2%)
-$26.79M(-66.3%)
Dec 2017
-$79.51M(+1.9%)
-$19.41M(-12.9%)
-$79.51M(+32.3%)
Sep 2017
-
-$22.29M(+22.9%)
-$60.10M(+58.9%)
Jun 2017
-
-$18.14M(-7.8%)
-$37.81M(+92.2%)
Mar 2017
-
-$19.68M
-$19.68M
Dec 2016
-$78.04M(+330.8%)
-
-
Dec 2015
-$18.11M
-
-

FAQ

  • What is Denali Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Denali Therapeutics?
  • What is Denali Therapeutics annual FCF year-on-year change?
  • What is Denali Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Denali Therapeutics?
  • What is Denali Therapeutics quarterly FCF year-on-year change?
  • What is Denali Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Denali Therapeutics?
  • What is Denali Therapeutics TTM FCF year-on-year change?

What is Denali Therapeutics annual free cash flow?

The current annual FCF of DNLI is -$363.61M

What is the all time high annual FCF for Denali Therapeutics?

Denali Therapeutics all-time high annual free cash flow is $413.06M

What is Denali Therapeutics annual FCF year-on-year change?

Over the past year, DNLI annual free cash flow has changed by +$7.32M (+1.97%)

What is Denali Therapeutics quarterly free cash flow?

The current quarterly FCF of DNLI is -$136.55M

What is the all time high quarterly FCF for Denali Therapeutics?

Denali Therapeutics all-time high quarterly free cash flow is $512.72M

What is Denali Therapeutics quarterly FCF year-on-year change?

Over the past year, DNLI quarterly free cash flow has changed by -$20.78M (-17.95%)

What is Denali Therapeutics TTM free cash flow?

The current TTM FCF of DNLI is -$384.38M

What is the all time high TTM FCF for Denali Therapeutics?

Denali Therapeutics all-time high TTM free cash flow is $415.39M

What is Denali Therapeutics TTM FCF year-on-year change?

Over the past year, DNLI TTM free cash flow has changed by +$40.73M (+9.58%)
On this page